Radionuclide scintigraphy with technetium-labeled bisphosphonates has brought a
paradigm shift in diagnosing cardiac amyloidosis (CA), with transthyretin CA now being …

Abstract Purpose of Review Cardiac amyloidosis (CA) is an often under-recognized cause of
heart failure with preserved ejection fraction. The goal of the current paper was to review …

Simple Summary Cardiac amyloidosis (CA) is characterized by extracellular infiltration and
deposition of amyloid fibrils primarily derived from the circulating transthyretin protein (TTR) …

Abstract Purpose of Review The aim of the present manuscript is to review the latest
advancements of radionuclide molecular imaging in the diagnosis and prognosis of …

Cardiac amyloidosis (CA) is a type of systemic amyloidosis, in which abnormal amyloid fibril
is deposited in extracellular space of myocardium. Most common subtypes of CA are …

The introduction of cardiac scintigraphy with bone-seeking tracers such as [99m Tc] Tc-
pyrophosphate as a highly accurate diagnostic test for transthyretin cardiac amyloidosis …

Cardiac amyloidosis (CA) is a hot topic in nuclear cardiology and molecular imaging has
become an important tool in the management of CA due to the unique capability to diagnose …

Amyloidosis is a disease characterized by depositions of amyloid in organs and tissues. It
can be localized (in just one organ) or systemic. Cardiac amyloidosis is a debilitating …

The gold standard for diagnosis of cardiac amyloidosis (CA) is endomyocardial biopsy
showing Congo red staining followed by mass spectroscopy, but the diagnosis can also be …

Cardiac amyloidosis, characterized by progressive restrictive cardiomyopathy, presents
unusual diagnostic challenges. Conventional cardiac scintigraphy has shown limited utility …